The Cellular Immune System of Patients with Acute Leukemia and Severe Chemotherapy-Induced Leukopenia: Characterization of T Lymphocyte Subsets Responsive to IL-16 and IL-17 | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

The Cellular Immune System of Patients with Acute Leukemia and Severe Chemotherapy-Induced Leukopenia: Characterization of T Lymphocyte Subsets Responsive to IL-16 and IL-17

Acta Haematol (2001) 104 (2-3): 80–91.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Immunosuppression and Immunotargeted Therapy in Acute Myeloid Leukemia - The Potential Use of Checkpoint Inhibitors in Combination with Other Treatments

Eva Leufven
Øystein Bruserud

Current Medicinal Chemistry (2019) 26 (28): 5244.

Functional Evaluation of Proliferative T Cell Responses in Patients with Severe T Lymphopenia: Characterization of Optimal Culture Conditions and Standardized Activation Signals for a Simple Whole Blood Assay

Øystein Wendelbo
Øystein Bruserud

Journal of Hematotherapy & Stem Cell Research (2003) 12 (5): 525.

Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia

Ø Bruserud

International Immunopharmacology (2001) 1 (12): 2183.

Biological treatment in acute myelogenous leukaemia: how should T-cell targeting immunotherapy be combined with intensive chemotherapy?

Øystein Wendelboe
Øystein Bruserud

Expert Opinion on Biological Therapy (2001) 1 (6): 1005.